COV

CLEO DIAGN FPO [COV]
Cleo Diagnostics Ltd, a biotechnology company, engages in the development and patent of a blood test for the detection of ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.
Healthcare · ASX Small Cap
$0.4000 +14.3%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-03-04
Get alerts when COV triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track COV — Free

Active Signals

Bullish Signals

  • MACD momentum is picking up steam
  • Pressing against the upper Bollinger Band — extended and may need to cool off
  • Just broke above 20-day resistance — a level that was capping price, now cleared
  • On a tear — up 15.9% over the last 5 days
  • Beating the Small Ords index — relative strength of 1.24, so it's outpacing the pack
  • Adequate cash runway (5 quarters)
  • Revenue in sharp decline (-100%)
  • Near 52-week low (7% of range)
  • Small-cap ($20-100M)
  • Capital raise activity (1 events)
  • Sentiment is mixed — no strong consensus either way
  • Altman Z-Score distress zone (1.66 < 1.81, low-confidence approx)
  • RBA hiking (-3pts)

Risk Signals

  • Stochastic is stretched into overbought — could need a breather
  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 25% over the past year
  • Revenue declining at -100% — the top line is shrinking
  • The bigger volume days are the down days — volume-weighted momentum is negative (-1.60%/day)
Ask Scout AI about COV
"What's driving COV today?" "How does COV compare to peers?" "Key risks for COV?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE CLEO Receives First Batch of Commercial Test Kits
NONE Change of Director's Interest Notice x 4
NONE Cleansing Notice
Announcement tone +3pts

Recent ASX Announcements

2026-09-02 CLEO Receives First Batch of Commercial Test Kits PRICE SENSITIVE
2026-08-24 Change of Director's Interest Notice x 4
2026-08-24 Cleansing Notice
2026-08-24 Application for quotation of securities - COV
2026-08-24 Notification of cessation of securities - COV

Key Metrics

$49.8M
Market Cap
80K
Avg Volume
1.1x
Vol Ratio
$0.31 — $0.90
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-109.5%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 56%
LLeader vs LaggardlaggardRS: -11
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

113 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
REG -27.0%CAN +25.0%BIT -20.0%MEM +20.0%CMP -14.6%
Compare:COV vs REGCOV vs CANCOV vs BIT
Scout Pro — Deeper Analysis for COV
Try Pro free for 30 days
Share this analysis

Track COV and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required